Biosimilar Erythropoietin in Anaemia Treatment (Maintenance Phase Study)
Clinical trial NCT02947438 · COMPLETED
Trial details
- NCT number
- NCT02947438
- Sponsor
- Shenyang Sunshine Pharmaceutical Co., LTD.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-01
- Primary completion
- 2021-10-09
- Enrollment
- 207
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.